Comments
Marksans Pharma on Thursday said it has received Establishment Inspection Report from the US FDA for its Goa facility. The inspection was carried out from February 25 to March 6. The company is engaged in research, manufacturing and marketing of generic pharmaceutical formulations in the global markets. Marksans’ manufacturing facilities are approved by regulatory agencies including UK MHRA, US FDA and Australia TGA.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.